Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: A prospective multicentre study
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. Background TNF-like weak inducer of apoptosis (TWEAK) is a proinflammatory molecule that plays a key role in active inflammation of lupus nephritis (LN). Urine TWEAK (uTWEAK) levels were found to be associated w...
Saved in:
Main Authors: | Thitima Benjachat Suttichet, Wonngarm Kittanamongkolchai, Chutipha Phromjeen, Sirirat Anutrakulchai, Thanachai Panaput, Atiporn Ingsathit, Nanticha Kamanamool, Vuddhidej Ophascharoensuk, Vasant Sumethakul, Yingyos Avihingsanon |
---|---|
Format: | Journal |
Published: |
2019
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065745297&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/65651 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: A prospective multicentre study
by: Thitima Benjachat Suttichet, et al.
Published: (2020) -
Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial
by: N. Kamanamool, et al.
Published: (2018) -
Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial
by: N. Kamanamool, et al.
Published: (2018) -
Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial
by: N. Kamanamool, et al.
Published: (2019) -
Lupus Nephritis : current concepts
by: Yingyos Avihingsanon, et al.
Published: (2006)